Hypertension and left ventricular geometry: Diagnosis, prognosis, and management
Open Access
- 2 June 2026
- journal article
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 25, 756-775
Abstract
Hypertension remains one of the most prevalent and consequential cardiovascular risk factors worldwide and is a leading cause of heart disease. Hypertensive heart disease may manifest in alterations in left ventricular (LV) geometry, including concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, representing adaptive responses to chronic pressure or volume overload that may progress to maladaptive remodeling and heart failure. LV geometric patterns, defined by LV mass and relative wall thickness, carry important diagnostic and prognostic implications independent of blood pressure levels. This review provides a comprehensive and contemporary overview of the relationship between hypertension and LV geometry. We summarize key determinants of hypertensive LV remodeling, including cumulative blood pressure exposure, sex differences, metabolic comorbidities, obesity, pericardial adiposity, and obstructive sleep apnea. We discuss current approaches to screening and diagnosis, highlighting the strengths and limitations of electrocardiography, echocardiography, and cardiac magnetic resonance imaging. We review emerging applications of artificial intelligence in electrocardiographic and echocardiographic assessment, with particular attention to their potential to improve detection, phenotypic differentiation, and prognostication. We further examine the prognostic significance of LV remodeling in hypertension and review evidence supporting regression of LV hypertrophy through intensive blood pressure control, management of comorbidities, and lifestyle interventions. Early identification and reversal of hypertensive LV remodeling may offer a critical opportunity to prevent progression to heart failure and reduce long-term cardiovascular morbidity and mortality.Keywords
This publication has 68 references indexed in Scilit:
- Effects of glucagon-like peptide-1 agents on left ventricular function: Systematic review and meta-analysisAnnals of Medicine, 2014
- Left Ventricular Hypertrophy Patterns and Incidence of Heart Failure With Preserved Versus Reduced Ejection FractionThe American Journal of Cardiology, 2014
- Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary AldosteronismHypertension, 2013
- Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studiesJournal of Human Hypertension, 2011
- Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE studyNutrition, Metabolism and Cardiovascular Diseases, 2009
- Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With AtenololCirculation, 2004
- Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five yearsJACC, 2004
- Left Ventricular Hypertrophy Is a Common Echocardiographic Abnormality in Severe Obstructive Sleep Apnea and Reverses With Nasal Continuous Positive Airway Pressure*Chest, 2003
- Reduction of Left Ventricular Hypertrophy After Exercise and Weight Loss in Overweight Patients With Mild HypertensionArchives of internal medicine (1960), 2002
- Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophyThe American Journal of Cardiology, 1996